Ceftriaxona Normon Innrennslisstofn, lausn 2000 mg Исланд - Исландски - LYFJASTOFNUN (Icelandic Medicines Agency)

ceftriaxona normon innrennslisstofn, lausn 2000 mg

laboratorios normon, s.a. - ceftriaxonum dínatríum - innrennslisstofn, lausn - 2000 mg

Ceftriaxona Normon Stungulyfs-/innrennslisstofn og leysir, lausn 1000 mg Исланд - Исландски - LYFJASTOFNUN (Icelandic Medicines Agency)

ceftriaxona normon stungulyfs-/innrennslisstofn og leysir, lausn 1000 mg

laboratorios normon, s.a. - ceftriaxonum dínatríum - stungulyfs-/innrennslisstofn og leysir, lausn - 1000 mg

Ringer-Acetat Baxter Viaflo Innrennslislyf, lausn Исланд - Исландски - LYFJASTOFNUN (Icelandic Medicines Agency)

ringer-acetat baxter viaflo innrennslislyf, lausn

baxter medical ab* - natrii chloridum; kalii chloridum; calcium chloride; magnesii chloridum; natrii acetas - innrennslislyf, lausn

Xenleta Европска Унија - Исландски - EMA (European Medicines Agency)

xenleta

nabriva therapeutics ireland dac - lefamulin acetate - pneumonia, bacterial; community-acquired infections - sýklalyf fyrir almenn nota, - xenleta is indicated for the treatment of community-acquired pneumonia (cap) in adults when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of cap or when these have failed. Íhuga ætti að opinbera leiðsögn á réttri notkun af sýklalyfjum.

Sivextro Европска Унија - Исландски - EMA (European Medicines Agency)

sivextro

merck sharp & dohme b.v. - tedizólíð fosfat - soft tissue infections; skin diseases, bacterial - antibacterials for systemic use, , other antibacterials - sivextro is indicated for the treatment of acute bacterial skin and skin structure infections (absssi) in adults and adolescents 12 years of age and older.